The journey of a novel bioconjugate into clinic is complex and uncertain. In this webinar, we explore the particular challenges when moving a bioconjugate candidate from early development into clinic. Our experts will share key considerations for de-risking this journey. From navigating the diverse conjugation technology landscape to designing a robust and scalable process through development. Several customer case studies will illustrate how Lonza’s expertise and integrated solutions have helped drug developers to bring their innovative therapeutics to life

Author: Sandro Holzer, Head of Process Development Bioconjugates, Lonza; Raphael Frey, Senior Scientist Bioconjugates, Lonza


Content Type: Webinar (on-demand)
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center